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PURPOSE. To determine whether the somatostatin receptor 2
(sst2) influences angiogenesis and its associated factors in a
model of hypoxia-induced retinal neovascularization.
METHODS. sst1-knockout (KO) mice, in which sst2 is overex-
pressed and overfunctional, and sst2-KO mice were used. An-
giogenesis was evaluated in fluorescein-perfused retinas. An-
giogenesis-associated factors were determined by RT-PCR and
immunohistochemistry.
RESULTS. Retinal neovascularization was increased in sst2-KO
mice, but remained unchanged in sst1-KO compared with
wild-type (WT) mice. Retinal levels of sst2 mRNA were not
affected by hypoxia. Normoxic levels of angiogenesis regula-
tors were similar in WT and KO retinas except for mRNA levels
of IGF-1, Ang-2, and its receptor Tie-2. In WT, hypoxia induced
an increase in mRNA levels of (1) VEGF and its receptors, (2)
IGF-1R, and (3) Ang-2 and Tie-2. The increase in VEGF and
IGF-1R mRNAs was more pronounced after sst2 loss, but was
less pronounced when sst2 was overexpressed. In addition, in
hypoxic retinas, sst2 loss increased IGF-1 mRNA, whereas it
decreased Ang-1, Tie-1, and Tie-2 mRNA levels. Moreover, Tie-1
mRNA increased when sst2 was overexpressed. Immunohisto-
chemistry confirmed the results in hypoxic retinas on in-
creased expression of VEGF, IGF-1, and their receptors after
sst2 loss. It also allowed the localization of these factors to
specific retinal cells. In this respect, VEGFR-2, IGF-1, and
IGF-1R were localized to Mu¨ller cells.
CONCLUSIONS. These results suggest that sst2 may be protective
against angiogenesis. The immediate clinical importance lies in
the establishment of a potential pharmacological target based
on sst2 pharmacology. (Invest Ophthalmol Vis Sci. 2007;48:
3480–3489) DOI:10.1167/iovs.06-1469
The abnormal formation of new blood vessels characterizesa variety of retinal diseases, including diabetic retinopa-
thy,1 and requires the involvement of vascular endothelial
growth factor (VEGF), insulin-like growth factor (IGF)-1, and
their receptors VEGFR-1, VEGFR-2, and IGF-1R. Although the
available information on their expression in the retina is far
from being exhaustive, these factors have been localized to
both retinal cells and microvascular endothelium.2–6 Retinal
neoangiogenesis is always associated with an increase of VEGF
and its receptors2,3,7 but not of IGF-1.8–10 Of the other down-
stream factors affecting blood vessel growth, recent results
indicate that Ang-1 and -2 and their tyrosine kinase receptor
Tie-2 are regulated by hypoxia and play a role in retinal neo-
vascularization.11,12 Although a ligand for Tie-1 has not been
found, it has recently been demonstrated that Ang-1 can induce
Tie-1 phosphorylation.13
The potential antiangiogenic role of the peptide somatosta-
tin-14 (SRIF) and its analogues has received much attention,14
and it involves partial correction of systemic growth hormone
dysregulation or inhibition of angiogenesis-associated fac-
tors.15–17 Of the five SRIF receptors mediating SRIF actions,
sst2 is a likely candidate to mediate the angioinhibitory activity
of SRIF. Indeed, analogues with high affinity for sst2, such as
octreotide and BIM23027, counteract the growth factor–in-
duced proliferation of bovine retinal endothelial cells under
hypoxia.18 They are powerful inhibitors of neovascularization
in models of proliferative retinopathies.15,19 In addition, oct-
reotide inhibits the IGF-1-mediated induction of VEGF in hu-
man retinal pigment epithelial (RPE) cells.16 Moreover, oct-
reotide retards retinopathy progression in diabetic patients in
whom photocoagulation has failed.20 However, despite the
growing use of sst2 agonists as antiangiogenic agents, the
mechanisms by which these peptides inhibit the growth of
new vessels has not been fully delineated.
Both sst1- and sst2-knockout (KO) mice have been gener-
ated.21,22 In their retinas, we have found that sst1 loss causes
an increased expression and function of sst2.
23–28
In the present study, retinas of sst1- and sst2-KO mice were
rendered hypoxic and were used to investigate whether al-
tered levels of sst2 play a role in regulating retinal angiogenesis
and its associated factors. Our hypothesis was that, compared
with wild-type (WT) retinas, the lack of sst2 is associated with
heavier effects of hypoxia, whereas a chronic overexpression
of sst2 (as in sst1-KO retinas) should attenuate these effects.
METHODS
Animals
Experiments were performed on 128 mice of WT (C57BL/6) and sst1-
or sst2-KO strains of both sexes at postnatal day (PD)17 (6 g body
weight). In some experiments designed to evaluate development of
retinal vasculature, five PD12 mice for each strain were also used. sst1-
and sst2-KO mice were generated as previously reported.
21,22 Experi-
ments were performed in agreement with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research and in compliance
with the Italian law on animal care 116/1992 and EEC/609/86. All
efforts were made to reduce the number of animals used.
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